Skip to main content

Alizarin Yellow R

ADVERTISEMENT
Identification
Molecular formula
C17H10O7
CAS number
523-44-4
IUPAC name
5-[(3-carboxy-4-hydroxy-phenyl)-(3-carboxy-4-oxo-cyclohexa-2,5-dien-1-ylidene)methyl]-2-hydroxy-benzoic acid
State
State

Alizarin Yellow R is typically in a solid state at room temperature, appearing as a fine, crystalline powder. Its color and form make it useful as a pH indicator and dye.

Melting point (Celsius)
235.00
Melting point (Kelvin)
508.15
Boiling point (Celsius)
420.00
Boiling point (Kelvin)
693.15
General information
Molecular weight
294.22g/mol
Molar mass
294.2220g/mol
Density
1.6780g/cm3
Appearence

Alizarin Yellow R is an orange to orangered crystalline powder. Its vivid color is due to the presence of chromophore groups within its molecular structure.

Comment on solubility

Solubility of 5-[(3-carboxy-4-hydroxy-phenyl)-(3-carboxy-4-oxo-cyclohexa-2,5-dien-1-ylidene)methyl]-2-hydroxy-benzoic acid (C17H10O7)

The solubility of 5-[(3-carboxy-4-hydroxy-phenyl)-(3-carboxy-4-oxo-cyclohexa-2,5-dien-1-ylidene)methyl]-2-hydroxy-benzoic acid is influenced by various factors, particularly its functional groups and molecular structure. This compound, containing multiple carboxylic acid groups, typically exhibits high solubility in polar solvents.

  • Polar Solvents: It is likely to be highly soluble in water due to the presence of carboxylic acid groups that can form hydrogen bonds.
  • Organic Solvents: The solubility in organic solvents such as ethanol or methanol will depend on the solvent's polarity; moderately polar organic solvents may facilitate better solubility.
  • pH Dependence: The solubility can also be pH-dependent; at lower pH values, the molecule may exist predominantly as the neutral form, whereas at higher pH levels, deprotonation can lead to increased solubility.

Overall, the compound's solubility profile can be summarized as follows:

  1. Highly soluble in water
  2. Variable solubility in organic solvents
  3. Dependent on pH conditions

Understanding the solubility characteristics of this compound is crucial for its application in various fields, including pharmaceuticals and material sciences.

Interesting facts

Interesting Facts About 5-[(3-carboxy-4-hydroxy-phenyl)-(3-carboxy-4-oxo-cyclohexa-2,5-dien-1-ylidene)methyl]-2-hydroxy-benzoic acid

This intriguing compound, commonly known for its complex structure, belongs to the class of organic acids characterized by its multiple functional groups. Here are some fascinating insights into this compound:

  • Diverse Functionalities: The presence of both carboxylic and hydroxyl groups makes this compound a potential candidate for various biochemical applications.
  • Potential Biological Activity: Compounds with similar structures have shown promising antioxidant and anti-inflammatory properties, suggesting this compound might be of interest in pharmacological studies.
  • Structure-Activity Relationship: The complexity of its structure can provide valuable insights into how various substituents influence biological activity, making it a candidate for studies in medicinal chemistry.
  • Naturally Occurring Analogues: This compound can be linked to naturally occurring plant polyphenols, which are widely recognized for their health benefits.
  • Applications in Green Chemistry: The synthesis of such compounds often employs methods that align with the principles of green chemistry, focusing on sustainability and environmental safety.

In summary, 5-[(3-carboxy-4-hydroxy-phenyl)-(3-carboxy-4-oxo-cyclohexa-2,5-dien-1-ylidene)methyl]-2-hydroxy-benzoic acid embodies a rich landscape of chemical functionalities and biological potential. Its study could pave the way for the development of novel therapeutic agents!

Synonyms
aurintricarboxylic acid
4431-00-9
Aluminon free acid
aurin tricarboxylic acid
NSC 4056
EINECS 224-628-1
NP9O8E29QW
BRN 2228904
CHEBI:87397
aurine tricarboxylic acid
MFCD00011663
5-[(3-carboxy-4-hydroxyphenyl)-(3-carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]-2-hydroxybenzoic acid
Benzoic acid, 5-((3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)-2-hydroxy-
chrome violet CG free acid
5,5'-(3-Carboxy-4-oxocyclohexa-2,5-dienylidenemethylene)di(salicylic acid)
1,4-Cyclohexadiene-1-carboxylic acid, 3-(bis(3-carboxy-4-hydroxyphenyl)methylene)-6-oxo-
5,5'-((3-Carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)methylene)bis(2-hydroxybenzoic acid)
MLS002153482
4-10-00-04161 (Beilstein Handbook Reference)
CAC 1098
NSC-4056
3,3'-[(3-carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)methylene]bis(6-hydroxybenzoic acid)
SMR000326731
CP 005240
Benzoic acid, 3,3'-((3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methylene)bis(6-hydroxy-
1,4-Cyclohexadiene-1-carboxylic acid, 3-[bis(3-carboxy-4-hydroxyphenyl)methylene]-6-oxo-
Benzoic acid, 5-[(3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl]-2-hydroxy-
Aurintricarboxylic Acids (Technical Grade)
NSC643698
Acid, Aurintricarboxylic
SR-01000075661
Acid, Aurin Tricarboxylic
3,3'-((3-carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)methylene)bis(6-hydroxybenzoic acid)
3,3'-[(3-Carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methylene]bis[6-hydroxybenzoic acid]
Benzoic acid, 3,3'-[(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methylene]bis[6-hydroxy-
Dupont ATA
3,3'-((3-CARBOXY-4-OXO-2,5-CYCLOHEXADIEN-1-YLIDENE)METHYLENE)BIS(6-HYDROXYBENZOIC ACID)
Lopac-A-1895
UNII-NP9O8E29QW
Aurintricarboxylicacid(ATA)
cid_2259
Lopac0_000054
SCHEMBL98495
SPECTRUM1505163
CHEMBL275938
DTXSID9063453
BDBM60996
HMS3260K09
Tox21_500054
AKOS015969706
AT15393
CCG-204149
LP00054
SDCCGSBI-0050042.P002
Dupont DA 639 (SD-095345)
NCGC00015040-01
NCGC00015040-02
NCGC00015040-03
NCGC00015040-04
NCGC00015040-05
NCGC00015040-06
NCGC00015040-08
NCGC00093568-01
NCGC00096052-01
NCGC00096052-02
NCGC00260739-01
5-[(3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxocyclohexa-2,5-dienylidene)methyl ]-2-hydroxybenzoic acid
DA-61324
MS-27411
HY-122575
CS-0087159
EU-0100054
NS00031410
A 1895
EN300-226544
Q4822390
SR-01000075661-1
SR-01000075661-7
Aurintricarboxylic acid, practical grade, >=85% (titration), powder
5,5'(3Carboxy4oxocyclohexa2,5dienylidenemethylene)di(salicylic acid)
1,4Cyclohexadiene1carboxylic acid, 3(bis(3carboxy4hydroxyphenyl)methylene)6oxo
Benzoic acid, 3,3'((3carboxy4oxo2,5cyclohexadien1ylidene)methylene)bis(6hydroxy
5-[(3-carboxy-4-hydroxy-phenyl)-(3-carboxy-4-keto-cyclohexa-2,5-dien-1-ylidene)methyl]-2-hydroxy-benzoic acid
5-[(3-carboxy-4-hydroxy-phenyl)-(3-carboxy-4-oxo-cyclohexa-2,5-dien-1-ylidene)methyl]-2-hydroxy-benzoic acid
5-[(3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]-2-hydroxybenzoic acid
5-[(3-carboxy-4-hydroxyphenyl)-(3-carboxy-4-oxo-1-cyclohexa-2,5-dienylidene)methyl]-2-hydroxybenzoic acid
5-[(3-carboxy-4-oxidanylidene-cyclohexa-2,5-dien-1-ylidene)-(3-carboxy-4-oxidanyl-phenyl)methyl]-2-oxidanyl-benzoic acid
Benzoic acid, 5((3carboxy4hydroxyphenyl)(3carboxy4oxo2,5cyclohexadien1ylidene)methyl)2hydroxy
Benzoic acid, 5-[(3-carboxy-4-hydroxyphenyl) (3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl]-2-hydroxy-